Package 0615-8580-39

Brand: potassium chloride

Generic: potassium chloride
NDC Package

Package Facts

Identity

Package NDC 0615-8580-39
Digits Only 0615858039
Product NDC 0615-8580
Description

30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK (0615-8580-39)

Marketing

Marketing Status
Marketed Since 2025-09-16
Brand potassium chloride
Generic potassium chloride
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "6a988bea-a4e8-4d1c-9a04-429932c1fa4a", "openfda": {"unii": ["660YQ98I10"], "rxcui": ["198116"], "spl_set_id": ["542e16b0-44db-490f-b44e-4c88a6e3d8b8"], "manufacturer_name": ["NCS HealthCare of KY, LLC dba Vangard Labs"]}, "finished": true, "packaging": [{"sample": false, "description": "15 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK (0615-8580-05)", "package_ndc": "0615-8580-05", "marketing_start_date": "20250916"}, {"sample": false, "description": "30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK (0615-8580-39)", "package_ndc": "0615-8580-39", "marketing_start_date": "20250916"}], "brand_name": "Potassium Chloride", "product_id": "0615-8580_6a988bea-a4e8-4d1c-9a04-429932c1fa4a", "dosage_form": "TABLET, FILM COATED, EXTENDED RELEASE", "pharm_class": ["Increased Large Intestinal Motility [PE]", "Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]", "Osmotic Activity [MoA]", "Osmotic Laxative [EPC]", "Potassium Compounds [CS]", "Potassium Salt [EPC]"], "product_ndc": "0615-8580", "generic_name": "Potassium Chloride", "labeler_name": "NCS HealthCare of KY, LLC dba Vangard Labs", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Potassium Chloride", "active_ingredients": [{"name": "POTASSIUM CHLORIDE", "strength": "1500 mg/1"}], "application_number": "ANDA212561", "marketing_category": "ANDA", "marketing_start_date": "20200201", "listing_expiration_date": "20261231"}